Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 26163-03-1 | MDL No. : | MFCD00955627 |
Formula : | C5H4BrClN2 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | UWGGGYYCKDCTGN-UHFFFAOYSA-N |
M.W : | 207.46 | Pubchem ID : | 2763971 |
Synonyms : |
|
Num. heavy atoms : | 9 |
Num. arom. heavy atoms : | 6 |
Fraction Csp3 : | 0.0 |
Num. rotatable bonds : | 0 |
Num. H-bond acceptors : | 1.0 |
Num. H-bond donors : | 1.0 |
Molar Refractivity : | 41.35 |
TPSA : | 38.91 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | No |
CYP1A2 inhibitor : | Yes |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -6.27 cm/s |
Log Po/w (iLOGP) : | 1.7 |
Log Po/w (XLOGP3) : | 1.82 |
Log Po/w (WLOGP) : | 2.09 |
Log Po/w (MLOGP) : | 1.6 |
Log Po/w (SILICOS-IT) : | 2.03 |
Consensus Log Po/w : | 1.85 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 0.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -2.77 |
Solubility : | 0.355 mg/ml ; 0.00171 mol/l |
Class : | Soluble |
Log S (Ali) : | -2.26 |
Solubility : | 1.15 mg/ml ; 0.00553 mol/l |
Class : | Soluble |
Log S (SILICOS-IT) : | -3.14 |
Solubility : | 0.15 mg/ml ; 0.000724 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 0.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 1.62 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H315-H319-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
93% | With bromine In chloroform at 20℃; for 1 h; | 5-Chloropyridin-2-amine (5000.0 mg, 38.90 mmol) was dissolved in CHCl3 (78.0 mL), and then Br2 (2.0 mL, 38.90 mmol) was added thereto. The reaction mixture was stirred at room temperature for one hour and solvent was removed therefrom under reduced pressure. The residue was dissolved in EtOAc, and it was then washed with saturated NaHCO3 aqueous solution and brine, dried over anhydrous Na2SO4, filtered and then distilled under reduced pressure. The residue was purified by column chromatography (EtOAc:n-Hex=1:9) on silica. The fractions containing the product were collected and evaporated to obtain yellow solid compound of 3-bromo-5-chloropyridin-2-amine (7500.0 mg, 93percent). [0621] LCMS ESI(+): 207 (M+1), 209 (M+3) [0622] 1H-NMR (300 MHz, CDCl3); δ: 7.98 (d, 1H, J=2.1 Hz), 7.66 (d, 1H, J=2.1 Hz), 4.93 (bs, 2H) |
88.1% | Stage #1: With bromine In chloroform at 20℃; for 0.5 h; Stage #2: With sodium hydrogensulfite In chloroform; water |
Step A: 3-bromo-5-chloropyridin-2-amine A 250 mLround-bottomed flask was charged with 5-chloropyridin-2-amine (80 g, 622.3 mmol) and CHCl3 (100 mL). Added bromine (31.98 mL, 622.3 mmol) and stirred at room temperature for 30 minutes. The reaction mixture was poured into saturated bicarbonate and NaHSO3 and extracted with CH2Cl2. The organic layer was dried with sodium sulfate, filtered and concentrated to afford the title compound (113.8 g, 88.1percent yield) as a tan solid. 1H NMR (d6-DMSO) δ 7.97 (d, 1H), 7.90 (d, 1H), 6.44 (bs, 2H). |
74% | at 10 - 20℃; for 2 h; | To 5-chloro-2-pyridineamine (3 g, 23.3 mmol) dissolved in acetic acid (40 ml) a solution of bromine (1.29 ml, 25 mmol) in acetic acid was added dropwise at 10°C. The mixture was stirred for 2 h at room temperature and then concentrated. Work-up and purification on a column packed with silica gel using 40percent ethyl acetate in heptane as an eluent yielded the title compound as a colourless powder (3.58 g, 74percent). |
71% | With N-Bromosuccinimide In acetonitrile at 80℃; for 1 h; | To a solution of 9 5-chloropyridin-2-amine (10g, 77.8mmol, 1 equiv.) in 31 acetonitrile (150mL), 10 N-bromosuccinimide (13.8g, 77.8mmol, 1 equiv.) was added. The reaction mixture was stirred and refluxed for 1h. Then the solvent was evaporated in vacuo. Compound 11 1 was obtained, after purification by chromatography on silica gel (eluent: dichloromethane–ethyl acetate 9:1) and recrystallization from propan-2-ol as a pale beige solid in 71percent yield. mp: 82°C, Lit.: 83–84°C; 1H NMR (400MHz, [D6]DMSO) δ: 6.43 (2H, s), 7.88 (1H, d, J=2.2Hz), 7.96 (1H, d, J=2.2Hz), 13C NMR (100MHz, [D6]DMSO) δ: 103.0 (C), 117.1 (C), 139.0 (CH), 145.0 (CH), 155.3 (C); MS ESI+ (m/z): 207.27/209.32 [M+H]+. |
70.4% | With N-Bromosuccinimide In ethanol; N,N-dimethyl-formamide at 85℃; for 3.5 h; | DMF and ethanol was added in a 50L round-bottomed three-necked flask volume ratio of 1: mixed solvent 18.7L 1.8, insert the thermometer and reflux condenser installation means, start with a magnetic stirrer, and adding 4986.6g of 2-amino-5- chloro pyridine, N- bromosuccinimide 17336.3g, at 85 reaction was stirred 3.5 hours, GC and TLC determined the completion of the reaction, the solvent was removed by rotary evaporation to give the crude product from n-hexane to give the pure product recrystallized from 2- amino-3-bromo-5-chloropyridine, after drying, the yield was calculated 70.4percent, a purity of 99.15percent. |
48% | With sodium hydroxide; bromine; sodium acetate In water; acetic acid | Example 2 A suspension of 2-amino-5-chloropyridine (5.14 g, 40 mmol) and anhydrous sodium acetate (3.29 g, 40 mmol) in acetic acid (25 mL) was mechanically stirred and warmed to a bath temperature of 45° C. A solution of bromine (2.1 mL, 40 mmol) in acetic acid (2 mL) was added over 1 hour. The resulting orange mixture was cooled to 15° C. and filtered. The solids were taken up in 400 mL of water, the suspension made basic by addition of 1 N NaOH and the suspension extracted with ethyl acetate (5*100 mL). The combined extracts were washed with 10percent NaHSO3(1*100 mL) and were dried over MgSO4. Concentration afforded 2-amino-3-bromo-5-chloropyridine (4 g, 48percent), mp 82-84° C. |
70.7% | With bromine; sodium acetate In water; acetic acid | EXAMPLE 1 2-Amino-3-bromo-5-chloropyridine An acetic acid (400 mL) suspension of sodium acetate (57.1 g, 0.696 mol) and 2-amino-5-chloropyridine (89.5 g, 0.696 mol) was treated with a solution of bromine (35.9 mL, 0.696 mol) in acetic acid (15 mL) over a period of 1.25 hours with gentle warming to 43° C. The resulting orange slurry was then cooled to 15° C. and filtered to provide a solid which was subsequently dissolved in water, basified (pH 8.5) with 1N NaOH, and extracted with ethyl acetate (5*150 mL). The combined organic layers were washed with 10percent sodium bisulfite (2*150 mL), dried over magnesium sulfate, and condensed to give 102.1 g (70.7percent) of a yellow solid, m.p. 83-85° C.: IR(CHCl3) 3683, 3504, 3401, 2987, 2482, 2392, 1608, 1571, 1544, 1455, 1389, 1316, 1207, 1127, 1057, 1026, 895, 881, 650, 607, 249, 236 cm-1; 1 H NMR (300 MHz, CDCl3) δ 5.20 (br s, 2H), 7.70 (d, 1H), J=2.2 Hz), 8.0 (d, 1H, J=2.2 Hz); 13 C NMR (CDCl3) δ 104.08, 120.33, 139.62, 145.24, 154.10; exact mass calculated for C5 H4 N2 BrCl=205.9246. High resolution mass spec. 205.9246. |
2.75 g | Stage #1: at 10 - 35℃; for 2 h; Stage #2: at 0℃; for 0.5 h; |
10716] To a solution of 5-chloropyridin-2-amine (5.0 g) in acetic acid (90 mE) was added dropwise a solution ofbromine (12.4 g) in acetic acid (4 mE) at 10° C. The reaction solution was stirred at room temperature for 2 hr, and saturated aqueous sodium thiosulfate solution was added thereto at 0° C. The mixture was stirred for 30 mm, the solvent was evaporated under reduced pressure, and the residue was extracted with ethyl acetate. The obtained organic layer was washed successively with saturated aqueous sodium bicarbonate solution and saturated brine, and dried over anhydrous magnesium sulfate, and the solvent was evaporated under reduced pressure. The residue was purified by silica gel column chromatography (ethyl acetate/hexane) to give the title compound (2.75 g).10717] ‘H NMR (300 MHz, CDC13) ö 4.92 (2H, brs), 7.66 (1H, d, J=2.3 Hz), 7.98 (1H, d, J=2.3 Hz). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
71.2% | With copper(l) iodide; tert.-butylnitrite; iodine In acetonitrile at 60℃; for 2 h; Inert atmosphere; Cooling with ice | Under nitrogen protection,Acetonitrile (100 mL) was added sequentially to a 500 mL three-necked flask,Elemental iodine (48.9 g, 192.8 mmol)Cuprous iodide (23.9 g, 125.3 mmol) andTert-butyl nitrite (14.9 g, 144.6 mmol)2-Amino-3-bromo-5-chloropyridine (20.0 g, 96.4 mmol) was slowly added under ice-cooling to react at 60 ° C for 2 h.After completion of the reaction, water (45 mL) was added,The filter cake was extracted with ethyl acetate (45 mL x 1) and the filtrate was extracted with ethyl acetate (200 mL x 2)The phases were washed with saturated aqueous sodium thiosulfate solution (110 mL x 2), dried over anhydrous sodium sulfate, and the solvent was evaporated under reduced pressure.A small amount of methanol beating, filter, filter cake after drying 2 - iodo-3-bromo-5-chloropyridine white solid 21.9g, the yield of 71.2percent. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
100% | With tetrakis(triphenylphosphine) palladium(0) In 1-methyl-pyrrolidin-2-one at 110℃; for 5 h; | 3-Bromo-5-chloropyridin-2-amine (2700.0 mg, 13.00 mmol) was dissolved in NMP (60.0 mL), and then Zn(CN)2 (2300.0 mg, 19.50 mmol) and Pd(PPh3)4 (1500.0 mg, 1.30 mmol) were added thereto. The reaction mixture was stirred at 110° C. for 5 hours and then cooled to room temperature. Water and EtOAc were added to the reaction mixture, and it was stirred for 10 minutes and then filtered through celite. The filtrate was extracted with EtOAc. The organic layer was washed with brine, dried over anhydrous Na2SO4, filtered and then distilled under reduced pressure. The residue was purified by column chromatography (EtOAc:n-Hex=1:9) on silica. The fractions containing the product were collected and evaporated to obtain white solid compound of 2-amino-5-chloronicotinonitrile (1900.0 mg, 100percent). [0624] LCMS ESI(+): 154 (M+1), 156 (M+3) [0625] 1H-NMR (300 MHz, DMSO-d6); δ: 8.22 (d, 1H, J=2.7 Hz), 8.07 (d, 1H, J=2.7 Hz), 7.14 (s, 2H) |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
89% | at 50℃; | A mixture of 3-bromo-5-chloropyridin-2-amine (10 g, 49 mmol) and chloroacetaldehyde (50percent in H2O, 12 mL, 98 mmol) in ethanol (100 mL) was heated at 50° C. overnight. It was then cooled to room temperature and concentrated. Acetone (30 mL) was added to the residue and the resulting mixture was stirred rapidly for 2 h. The resulting solid was collected through filtration and dried to afford 101a as a yellow solid (10.0 g, 89percent). MS: [M+H]+231. 1H NMR (500 MHz, DMSO) δ 9.20 (s, 1H), 8.33 (s, 1H), 8.29 (s, 1H), 8.09 (s, 1H) |
55.2% | for 3 h; Reflux | Example 39 2'-amino-6-(6-chloroimidazo[ 1 ,2-a]pyridin-8-yl)- 1 ',2,2-trimethylspiro[chroman-4,4'- imidazol]-5'(l'H)-oneStep A: 3-Bromo-5-chloro-2-pyridinamine (487 mg, 2.35 mmol) was diluted with ethanol (4 mL), followed by the addition of 2-chloroacetaldehyde (614 , 4.69 mmol). The reaction was heated at reflux for 3 hours. The reaction was cooled and loaded onto silica gel eluting with 10-50percent ethyl acetate/hexanes to yield 8-bromo-6-chloroimidazo[l,2-a]pyridine (300 mg, 1.30 mmol, 55.2percent yield).Step B: 2'-Amino-r,2,2-trimethyl-6-(4,4,5,5-tetramethyl |
[ 221297-82-1 ]
3-Bromo-4-chloropyridin-2-amine
Similarity: 0.88
[ 1263214-75-0 ]
N-(3-Bromo-5-chloropyridin-2-yl)formamide
Similarity: 0.81
[ 1187449-01-9 ]
4-Bromo-5-chloropyridin-2-amine
Similarity: 0.78
[ 221297-82-1 ]
3-Bromo-4-chloropyridin-2-amine
Similarity: 0.88
[ 1263214-75-0 ]
N-(3-Bromo-5-chloropyridin-2-yl)formamide
Similarity: 0.81
[ 1187449-01-9 ]
4-Bromo-5-chloropyridin-2-amine
Similarity: 0.78
[ 221297-82-1 ]
3-Bromo-4-chloropyridin-2-amine
Similarity: 0.88
[ 1263214-75-0 ]
N-(3-Bromo-5-chloropyridin-2-yl)formamide
Similarity: 0.81
[ 1187449-01-9 ]
4-Bromo-5-chloropyridin-2-amine
Similarity: 0.78
[ 221297-82-1 ]
3-Bromo-4-chloropyridin-2-amine
Similarity: 0.88
[ 1263214-75-0 ]
N-(3-Bromo-5-chloropyridin-2-yl)formamide
Similarity: 0.81
[ 1187449-01-9 ]
4-Bromo-5-chloropyridin-2-amine
Similarity: 0.78